Emerging pathogens - How safe is blood?

Transfusion Medicine and Hemotherapy

Volumn 41, Issue 1, 2014, Pages 10-17

  Schmidt, Michael ^a   Geilenkeuser, Wolf Jochen ^a   Sireis, Walid ^b   Seifried, Erhard ^b   Hourfar, Kai ^b  

^a DGKL Reference Institute for Bioanalytics   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Babesia; Blood safety; Chagas disease; Dengue virus; Malaria

Indexed keywords

BABESIA INFECTION; BLOOD COMPONENT; BLOOD COMPONENT THERAPY; CHAGAS DISEASE; DENGUE; DENGUE VIRUS; HUMAN; INFECTION RISK; MALARIA; PARASITOSIS; PLASMODIUM; REVIEW; SCREENING;

EID: 84902536593     PISSN: 16603796     EISSN: 16603818     Source Type: Journal    
DOI: 10.1159/000358017     Document Type: Review

References (89)

1. Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ: Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis c virus, and hepatitis b virus. Transfusion 2008;48:1558-1566.
2. Muller MM, Fraile MI, Hourfar MK, Peris LB, Sireis W, Rubin MG, Lopez EM, Rodriguez GT, Seifried E, Saldanha J, Schmidt M: Evaluation of two, commercial, multi-dye, nucleic acid amplification technology tests, for HBV/HCV/HIV-1/HIV-2 and B19V/HAV, for screening blood and plasma for further manufacture. Vox Sang 2013;104:19-29.
3. Stramer SL, Krysztof DE, Brodsky JP, Fickett TA, Reynolds B, Phikulsod S, Oota S, Lin M, Saldanha J, Kleinman SH: Sensitivity comparison of two food and drug administration-licensed, triplex nucleic acid test automated assays for hepatitis b virus DNA detection and associated projections of United States yield. Transfusion 2011;51:2012-2022.
4. Roth WK, Busch MP, Schuller A, Ismay S, Cheng A, Seed CR, Jungbauer C, Minsk PM, Sondag-Thull D, Wendel S, Levi JE, Fearon M, Delage G, Xie Y, Jukic I, Turek P, Ullum H, Tefanova V, Tilk M, Reimal R, Castren J, Naukkarinen M, Assal A, Jork C, Hourfar MK, Michel P, Offergeld R, Pichl L, Schmidt M, Schottstedt V, Seifried E, Wagner F, Weber-Schehl M, Politis C, Lin CK, Tsoi WC, O'Riordan J, Gottreich A, Shinar E, Yahalom V, Velati C, Satake M, Sanad N, Sisene I, Bon AH, Koppelmann M, Flanagan P, Flesland O, Brojer E, Letowska M, Nascimento F, Zhiburt E, Chua SS, Teo D, Stezinar SL, Vermeulen M, Reddy R, Park Q, Castro E, Eiras A, Gonzales Fraile I, Torres P, Ekermo B, Niederhauser C, Chen H, Oota S, Brant LJ, Eglin R, Jarvis L, Mohabir L, Brodsky J, Foster G, Jennings C, Notari E, Stramer S, Kessler D, Hillyer C, Kamel H, Katz L, Taylor C, Panzer S, Reesink HW: International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang 2012;102:82-90.
5. Roth WK, Weber M, Seifried E: Feasibility and efficacy of routine PCR screening of blood donations for hepatitis c virus, hepatitis b virus, and HIV-1 in a blood-bank setting. Lancet 1999;353:359-363.
6. Roth WK, Buhr S, Drosten C, Seifried E: NAT and viral safety in blood transfusion. Vox Sang 2000; 78(suppl 2):257-259.
7. Funk MB, Lohmann A, Guenay S, Henseler O, Heiden M, Hanschmann KM, Keller-Stanislawski B: Transfusion-transmitted bacterial infections-haemovigilance data of German blood establishments (1997-2010). Transfus Med Hemother 2011; 38:266-271.
8. Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit: Festlegung der Haltbarkeitsfrist von Thrombozytenkonzentraten mit dem Ziel der Reduktion lebensbedrohlicher septischer Transfusionsreaktionen durch bakterielle Kontamination. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2008;51:1484.
9. Dreier J, Vollmer T, Kleesiek K: Novel flow cytometry-based screening for bacterial contamination of donor platelet preparations compared with other rapid screening methods. Clin Chem 2009;55: 1492-1502.
10. Vollmer T, Kleesiek K, Dreier J: Detection of bacterial contamination in platelet concentrates using flow cytometry and real-time PCR methods. Methods Mol Biol 2013;943:91-103.
11. Dreier J, Stormer M, Kleesiek K: Real-time polymerase chain reaction in transfusion medicine: applications for detection of bacterial contamination in blood products. Transfus Med Rev 2007;21: 237-254.
12. Dreier J, Stormer M, Kleesiek K: Two novel realtime reverse transcriptase PCR assays for rapid detection of bacterial contamination in platelet concentrates. J Clin Microbiol 2004;42:4759-4764.
13. Sireis W, Hourfar MK, Seifried E, Schmidt M: How to improve blood safety with respect to bacterial contaminations? Vox Sang 2012;103:87-88.
14. Osselaer JC, Doyen C, Defoin L, Debry C, Goffaux M, Messe N, Van Hooydonk M, Bosly A, Lin JS, Lin L, Corash L: Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use. Transfusion 2009;49:1412-1422.
15. Irsch J, Lin L: Pathogen inactivation of platelet and plasma blood components for transfusion using the intercept blood system. Transfus Med Hemother 2011;38:19-31.
16. Picker SM, Steisel A, Gathof BS: Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. Transfusion 2008;48:1685-1692.
17. Goodrich RP, Edrich RA, Li J, Seghatchian J: The Mirasol PRT system for pathogen reduction of platelets and plasma: an overview of current status and future trends. Transfus Apher Sci 2006;35:5-17.
18. Seghatchian J, Tolksdorf F: Characteristics of the THERAFLEX UV-platelets pathogen inactivation system-An update. Transfus Apher Sci 2012;46: 221-229.
19. Arbeitskreis Blut, Untergruppe Bewertung Blutassoziierter Krankheitserreger. Malaria. Transfus Med Hemother 2009;36:48-60.
20. Mitteilungen des Arbeitskreises Blut des Bundesministeriums für Gesundheit: Dengue Fieber Virus (DENV) Bundesgesundheitsbl 2011;54:892-904.
21. Anstey NM, Douglas NM, Poespoprodjo JR, Price RN: Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol 2012;80:151-201.
22. Douglas NM, Anstey NM, Buffet PA, Poespoprodjo JR, Yeo TW, White NJ, Price RN: The anaemia of Plasmodium vivax malaria. Malaria J 2012;11:135.
23. Cullen KA, Arguin PM: Malaria surveillance-United States, 2011. MMWR Surveill Summ 2013;62(suppl 5):1-17.
24. Fletcher TE, Beeching NJ: Malaria. J R Army Med Corps 2013;159:158-166.
25. Eckhoff PA: Malaria parasite diversity and transmission intensity affect development of parasitological immunity in a mathematical model. Malaria J 2012;11:419.
26. Pathak S, Chandrashekhar M: Transfusion transmittable infections-seroprevalence among blood donors in a tertiary care hospital of Delhi. Asian J Transfus Sci 2013;7:116-118.
27. Tagny CT, Owusu-Ofori S, Mbanya D, Deneys V: The blood donor in sub-Saharan Africa: a review. Transfus Med 2010;20:1-10.
28. Kinde G, Oke J, Gnahoui I, Massougbodji A: The risk of malaria transmission by blood transfusion at Cotonou, Benin (in French). Sante 2000;10:389-392.
29. Witt O, Iglauer ARJ, Bommer W, Eber S: Transfusionsmalaria als Ursache von unklarem postoperativen Fieber. Monatsschr Kinderheilkd 1998;146: 1054-1056.
30. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL: Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 2013;341:1359-1365.
31. Reyburn H, Mbakilwa H, Mwangi R, Mwerinde O, Olomi R, Drakeley C, Whitty CJ: Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ 2007;334:403.
32. Benito A, Rubio JM: Usefulness of seminested polymerase chain reaction for screening blood donors at risk for malaria in Spain. Emerg Infect Dis 2001;7:1068.
33. Kitchen AD, Chiodini PL: Malaria and blood transfusion. Vox Sang 2006;90:77-84.
34. Henschler R, Seifried E, Mufti N: Development of the s-303 pathogen inactivation technology for red blood cell concentrates. Transfus Med Hemother 2011;38:33-42.
35. El Chaar M, Atwal S, Freimanis GL, Dinko B, Sutherland CJ, Allain JP: Inactivation of Plasmodium falciparum in whole blood by riboflavin plus irradiation. Transfusion 2013;53:3174-3183.
36. Deen JL, Harris E, Wills B, Balmaseda A, Hammond SN, Rocha C, Dung NM, Hung NT, Hien TT, Farrar JJ: The WHO dengue classification and case definitions: time for a reassessment. Lancet 2006;368:170-173.
37. Neyts J, Leyssen P, De Clercq E: Infections with flaviviridae. Verhandelingen-Koninklijke Academie voor Geneeskunde van Belgie 1999;61:661-697; discussion 697-669.
38. Igarashi A: Impact of dengue virus infection and its control. FEMS Immunol Med Microbiol 1997;18: 291-300.
39. Martins VE, Alencar CH, Kamimura MT, de Carvalho Araujo FM, De Simone SG, Dutra RF, Guedes MI: Occurrence of natural vertical transmission of dengue-2 and dengue-3 viruses in Aedes aegypti and Aedes albopictus in Fortaleza, Ceara, Brazil. PloS one 2012;7:e41386.
40. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI: The global distribution and burden of dengue. Nature 2013;496:504-507.
41. Manda H, Shah P, Polsomboon S, Chareonviriyaphap T, Castro-Llanos F, Morrison A, Burrus RG, Grieco JP, Achee NL: Contact irritant responses of Aedes aegypti using sublethal concentration and focal application of pyrethroid chemicals. PLoS Negl Trop Dis 2013;7:e2074.
42. Carrington LB, Seifert SN, Armijos MV, Lambrechts L, Scott TW: Reduction of aedes aegypti vector competence for dengue virus under large temperature fluctuations. Am J Trop Med Hyg 2013;88:689-697.
43. Batista MV, Pierrotti LC, Abdala E, Clemente WT, Girao ES, Rosa DR, Ianhez LE, Bonazzi PR, Lima AS, Fernandes PF, Padua-Neto MV, Bacchella T, Oliveira AP, Viana CF, Ferreira MS, Shikanai-Yasuda MA: Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 2011;16:1134-1142.
44. Stramer SL, Linnen JM, Carrick JM, Foster GA, Krysztof DE, Zou S, Dodd RY, Tirado-Marrero LM, Hunsperger E, Santiago GA, Munoz-Jordan JL, Tomashek KM: Dengue viremia in blood donors identified by RNA and detection of dengue transfusion transmission during the 2007 dengue outbreak in Puerto Rico. Transfusion 2012;52:1657-1666.
45. Calzolari M, Ze-Ze L, Ruzek D, Vazquez A, Jeffries C, Defilippo F, Osorio HC, Kilian P, Ruiz S, Fooks AR, Maioli G, Amaro F, Tlusty M, Figuerola J, Medlock JM, Bonilauri P, Alves MJ, Sebesta O, Tenorio A, Vaux AG, Bellini R, Gelbic I, Sanchez-Seco MP, Johnson N, Dottori M: Detection of mosquito-only flaviviruses in Europe. Jo Gen Virol 2012;93:1215-1225.
46. Hu D, Di B, Ding X, Wang Y, Chen Y, Pan Y, Wen K, Wang M, Che X: Kinetics of non-structural protein 1, IgM and IgG antibodies in dengue type 1 primary infection. Virol J 2011;8:47.
47. Bessoff K, Phoutrides E, Delorey M, Acosta LN, Hunsperger E: Utility of a commercial nonstructural protein 1 antigen capture kit as a dengue virus diagnostic tool. Clin Vaccine Immunology 2010;17: 949-953.
48. Schmidt-Chanasit J, Schmiedel S, Fleischer B, Burchard GD: Viruses acquired abroad: What does the primary care physician need to know? Dtsch Arztebl Int 2012;109:681-691; quiz 692.
49. Lemmer K, Donoso Mantke O, Bae HG, Groen J, Drosten C, Niedrig M: External quality control assessment in PCR diagnostics of dengue virus infections. J Clin Virol 2004;30:291-296.
50. Tan SS, Bujang MA: The clinical features and outcomes of acute liver failure associated with dengue infection in adults: a case series. Braz J Infect Dis. 2013;17:164-169.
51. Robert Koch-Institut: SurvStat, www3.rki.de/SurvStat, Date:2013-11-18.
52. La Ruche G, Souares Y, Armengaud A, Peloux-Petiot F, Delaunay P, Despres P, Lenglet A, Jourdain F, Leparc-Goffart I, Charlet F, Ollier L, Mantey K, Mollet T, Fournier JP, Torrents R, Leitmeyer K, Hilairet P, Zeller H, Van Bortel W, Dejour-Salamanca D, Grandadam M, Gastellu-Etchegorry M: First two autochthonous dengue virus infections in metropolitan France, September 2010. Euro Surveill 2010;15:19676.
53. Gjenero-Margan I, Aleraj B, Krajcar D, Lesnikar V, Klobucar A, Pem-Novosel I, Kurecic-Filipovic S, Komparak S, Martic R, Duricic S, Betica-Radic L, Okmadzic J, Vilibic-Cavlek T, Babic-Erceg A, Turkovic B, Avsic-Zupanc T, Radic I, Ljubic M, Sarac K, Benic N, Mlinaric-Galinovic G: Autochthonous dengue fever in Croatia, August-September 2010. Euro Surveill 2011;16:19805.
54. Frank C, Hohle M, Stark K, Lawrence J: More reasons to dread rain on vacation? Dengue fever in 42 German and United Kingdom Madeira tourists during autumn 2012. Euro Surveill 2013;18:20446.
55. Pluskota B, Storch V, Braunbeck T, Beck M, Becker N: First record of Stegomyia albopicta (Skuse) (Diptera: Culicidae) in Germany. Eur Mosquito Bull 2008;26: 1-5
56. Liumbruno GM, Calteri D, Petropulacos K, Mattivi A, Po C, Macini P, Tomasini I, Zucchelli P, Silvestri AR, Sambri V, Pupella S, Catalano L, Piccinini V, Calizzani G, Grazzini G: The chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus 2008;6:199-210.
57. Wiwanitkit V: Unusual mode of transmission of dengue. J Infect Dev Ctries 2009;4:51-54.
58. Petersen LR, Busch MP: Transfusion-transmitted arboviruses. Vox Sang 2010;98:495-503.
59. Phongsamart W, Yoksan S, Vanaprapa N, Chokephaibulkit K: Dengue virus infection in late pregnancy and transmission to the infants. Pediatr Infect Dis J 2008;27:500-504.
60. Chuang V, Wong TY, Leung YH, Ma E, Law YL, Tsang O, Chan KM, Tsang I, Que TL, Yung R, Liu SH: Review of dengue fever cases in Hong Kong during 1998 to 2005. Hong Kong Med J 2008;14:170-177.
61. Tambyah PA, Koay ES, Poon ML, Lin RV, Ong BK: Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008;359:1526-1527.
62. Halperin D, Baetens J, Newman B: The effect of short-term, temporary deferral on future blood donation. Transfusion 1998;38:181-183.
63. Mohammed H, Linnen JM, Munoz-Jordan JL, Tomashek K, Foster G, Broulik AS, Petersen L, Stramer SL: Dengue virus in blood donations, Puerto Rico, 2005. Transfusion 2008;48:1348-1354.
64. Fajardo A, Recarey R, de Mora D, L DA, Alvarez M, Regato M, Colina R, Khan B, Cristina J: Modeling gene sequence changes over time in type 3 dengue viruses from Ecuador. Vir Res 2009;141:105-109.
65. Chagas C: Human existence, disease, and the natural sciences (in French). BullAcad Natl Med 1972; 156(suppl):16-21.
66. Wilson LS, Ramsey JM, Koplowicz YB, Valiente-Banuet L, Motter C, Bertozzi SM, Tobler LH: Cost-effectiveness of implementation methods for ELISA serology testing of Trypanosoma cruzi in California blood banks. AmJ Trop Med Hyg 2008; 79:53-68.
67. Schmunis GA, Zicker F, Cruz JR, Cuchi P: Safety of blood supply for infectious diseases in Latin American countries, 1994-1997. Am J Trop Med Hyg 2001;65:924-930.
68. Van Voorhis WC, Barrett LK, Eastman RT, Alfonso R, Dupuis K: Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV. Antimicrob Agents Chemother 2003;47:475-479.
69. Gray JS: Identity of the causal agents of human babesiosis in Europe. Int J Med Microbiol 2006; 296(suppl 40):131-136.
70. Hunfeld KP, Lambert A, Kampen H, Albert S, Epe C, Brade V, Tenter AM: Seroprevalence of babesia infections in humans exposed to ticks in midwestern Germany. J Clin Microbiol 2002;40:2431-2436.
71. Fitzpatrick JE, Kennedy CC, McGeown MG, Oreopoulos DG, Robertson JH, Soyannwo MA: Human case of piroplasmosis (babesiosis). Nature 1968;217:861-862.
72. Vannier E, Borggraefe I, Telford SR 3rd, Menon S, Brauns T, Spielman A, Gelfand JA, Wortis HH: Age-Associated decline in resistance to Babesia microti is genetically determined. J Infect Dis 2004; 189:1721-1728.
73. Esernio-Jenssen D, Scimeca PG, Benach JL, Tenenbaum MJ: Transplacental/perinatal babesiosis. J Pediatr 1987;110:570-572.
74. New DL, Quinn JB, Qureshi MZ, Sigler SJ: Vertically transmitted babesiosis. J Pediatr 1997;131: 163-164.
75. Sethi S, Alcid D, Kesarwala H, Tolan RW Jr.: Probable congenital babesiosis in infant, New Jersey, USA. Emerg Infect Dis 2009;15:788-791.
76. Lux JZ, Weiss D, Linden JV, Kessler D, Herwaldt BL, Wong SJ, Keithly J, Della-Latta P, Scully BE: Transfusion-Associated babesiosis after heart transplant. Emerg Infect Dis 2003;9:116-119.
77. Ramharter M, Walochnik J, Lagler H, Winkler S, Wernsdorfer WH, Stoiser B, Graninger W: Clinical and molecular characterization of a near fatal case of human babesiosis in Austria. J Travel Med 2010; 17:416-418.
78. Hunfeld KP, Hildebrandt A, Gray JS: Babesiosis: recent insights into an ancient disease. Int J Parasitol 2008;38:1219-1237.
79. Chisholm ES, Ruebush TK 2nd, Sulzer AJ, Healy GR: Babesia microti infection in man: evaluation of an indirect immunofluorescent antibody test. Am J Trop Med Hyg 1978;27:14-19.
80. Krause PJ, Spielman A, Telford SR 3rd, Sikand VK, McKay K, Christianson D, Pollack RJ, Brassard P, Magera J, Ryan R, Persing DH: Persistent parasitemia after acute babesiosis. N Engl J Med 1998;339:160-165.
81. Grellier P, Benach J, Labaied M, Charneau S, Gil H, Monsalve G, Alfonso R, Sawyer L, Lin L, Steiert M, Dupuis K: Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components. Transfusion 2008;48:1676-1684.
82. Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA: Evaluation of the mirasol pathogen reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion 2010;50:1019-1027.
83. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA: Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009;49:2557-2563.
84. Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA: Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood. Transfusion 2012; 52:409-416.
85. Seghatchian J, Struff WG, Reichenberg S: Main properties of the THERAFLEX MB-plasma system for pathogen reduction. Transfus Med Hemother 2011;38:55-64.
86. Leiby DA, Nguyen ML, Notari EP: Impact of donor deferrals for malaria on blood availability in the United States. Transfusion 2008;48:2222-2228.
87. Tonnetti L, Thorp AM, Deisting B, Bachowski G, Johnson ST, Wey AR, Hodges JS, Leiby DA, Mair D: Babesia microti seroprevalence in Minnesota blood donors. Transfusion 2013;53:1698-1705.
88. Johnson ST, Van Tassell ER, Tonnetti L, Cable RG, Berardi VP, Leiby DA: Babesia microti realtime polymerase chain reaction testing of Connecticut blood donors: potential implications for screening algorithms. Transfusion 2013;53:2644-2649.
89. Leiby DA, Herron RM Jr., Garratty G, Herwaldt BL: Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis 2008;198:609-613.